|4Feb 22, 4:57 PM ET

Quinn Anthony G. 4

4 · Aeglea BioTherapeutics, Inc. · Filed Feb 22, 2022

Insider Transaction Report

Form 4
Period: 2022-02-17
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-02-17+350,000350,000 total
    Exercise: $3.17Exp: 2032-02-16Common Stock (350,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2022, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION